Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             118 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case of large cell carcinoma of the lung producing granulocyte colony-stimulating factor 1994
11 5-6 p. 435-
1 p.
artikel
2 A case of recurrent non-small cell lung cancer well responded to the oral etoposide therapy 1994
11 5-6 p. 440-441
2 p.
artikel
3 Acknowledgement of the Czech travel awardees on participation in the 7th World Conference on Lung Cancer in Colorado Springs, June 26–July 1, 1994 1994
11 5-6 p. 409-
1 p.
artikel
4 A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer Klastersky, J.
1994
11 5-6 p. 373-384
12 p.
artikel
5 A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung Hosoe, S
1994
11 5-6 p. 429-
1 p.
artikel
6 A 3-Mb physical map of the chromosome region 8p21.3-p22, including a 600-kb region commonly deleted in human hepatocellular carcinoma, colorectal cancer, and non-small cell lung cancer 1994
11 5-6 p. 428-429
2 p.
artikel
7 A Phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer Furuse, Kiyoyuki
1994
11 5-6 p. 385-391
7 p.
artikel
8 A pilot study of combination chemotherapy for poor PS patients with small cell lung cancer 1994
11 5-6 p. 439-
1 p.
artikel
9 A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer 1994
11 5-6 p. 441-442
2 p.
artikel
10 Are pathologists biased by clinical information?: a blinded cross-over study of the histopathological diagnosis of mesothelial tumours versus pulmonary adenocarcinoma Skov, Birgit G.
1994
11 5-6 p. 365-372
8 p.
artikel
11 A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis 1994
11 5-6 p. 428-
1 p.
artikel
12 Are we moving towards continuous treatment in small cell lung cancer (SCLC)? 1994
11 5-6 p. 439-
1 p.
artikel
13 Arterial infusion chemotherapy and embolization of bronchial artery in the treatment of lung cancer 1994
11 5-6 p. 439-
1 p.
artikel
14 Aryl hydrocarbon hydroxylase activity in human lung tissue: In relation to cigarette smoking and lung cancer 1994
11 5-6 p. 425-
1 p.
artikel
15 Biology of lung cancer 1994
11 5-6 p. 442-
1 p.
artikel
16 Biology of lung cancer 1994
11 5-6 p. 431-432
2 p.
artikel
17 Campaigns against smoking: Compliance and results 1994
11 5-6 p. 424-
1 p.
artikel
18 Carboplatin, epirubicin, and VP-16 chemotherapy in the treatment of small cell lung cancer 1994
11 5-6 p. 440-
1 p.
artikel
19 Carcinogen-specific mutations in the p53 tumor suppressor gene in lung cancer 1994
11 5-6 p. 429-
1 p.
artikel
20 Chemoprevention of respiratory tract neoplasia in the hamster by oltipraz, alone and in combination 1994
11 5-6 p. 424-
1 p.
artikel
21 Chemotherapy dose intensity in small cell lung cancer 1994
11 5-6 p. 438-
1 p.
artikel
22 Chemotherapy of lung cancer 1994
11 5-6 p. 442-
1 p.
artikel
23 Clinical and methodological reliability of an immunoradiometric assay for the new lung cancer marker: Cyfra 21-1 1994
11 5-6 p. 434-435
2 p.
artikel
24 Clinical significance of serum BFP and various tumor markers in primary lung cancer 1994
11 5-6 p. 433-434
2 p.
artikel
25 Clinical study of bronchioloalveolar cell carcinoma Choi, JW
1994
11 5-6 p. 433-
1 p.
artikel
26 Clinical study of intrapleural administration of pirarubicin (THP-ADM) for treatment of malignant pleural effusion secondary to lung cancer 1994
11 5-6 p. 441-
1 p.
artikel
27 Clofazimine alters the energy metabolism and inhibits the growth rate of a human lung-cancer cell line in vitro and in vivo 1994
11 5-6 p. 431-
1 p.
artikel
28 c-myc Expression correlates with suppression of c-kit protooneogene expression in small cell lung cancer cell lines 1994
11 5-6 p. 427-
1 p.
artikel
29 Combination of vinorelbine, cisplatin, and etoposide in advanced non-small cell lung carcinoma: A pilot study 1994
11 5-6 p. 440-
1 p.
artikel
30 Comparison of two chemotherapeutic regimens - mitomycin + vindesine + cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP) - in advanced non-small-cell lung cancer 1994
11 5-6 p. 438-
1 p.
artikel
31 Critical care of intrathoracic complications of lung cancer 1994
11 5-6 p. 436-
1 p.
artikel
32 Current status of lung cancer diagnosis and treatment in Shanghai 1994
11 5-6 p. 443-
1 p.
artikel
33 Cyfra 21-1, a new marker of lung cancer 1994
11 5-6 p. 434-
1 p.
artikel
34 Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer - Results of an international multicentre study 1994
11 5-6 p. 435-
1 p.
artikel
35 Detailed deletion mapping of the short arm of chromosome 3 in small cell and non-small cell carcinoma of the lung Hosoe, S
1994
11 5-6 p. 430-
1 p.
artikel
36 Detection of oncogene mutations in sputum precedes diagnosis of lung cancer 1994
11 5-6 p. 429-430
2 p.
artikel
37 Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies 1994
11 5-6 p. 428-
1 p.
artikel
38 Differences of E-cadherin expression levels and patterns in human lung cancer 1994
11 5-6 p. 432-
1 p.
artikel
39 Disappearance curves of tumor markers after radical surgery 1994
11 5-6 p. 436-
1 p.
artikel
40 Does adjuvant chemotherapy decrease distant metastasis formation in patients with non-small cell lung cancer? 1994
11 5-6 p. 438-
1 p.
artikel
41 Does clinical experience with a treatment regimen affect survival of lung cancer patients? An analysis based on consecutive randomized trials of the Medical Research Council in small cell and non-small cell tumours 1994
11 5-6 p. 444-
1 p.
artikel
42 Dose intensity of the CAVE regimen in small cell lung cancer correlates to response rate Sirzea, Florin
1994
11 5-6 p. 393-400
8 p.
artikel
43 Editor's note Hansen, Heine H.
1994
11 5-6 p. 411-
1 p.
artikel
44 Epidemiological studies on lung cancer in the Bohemia region 1994
11 5-6 p. 426-
1 p.
artikel
45 Epidemiology, screening, and prevention of lung cancer 1994
11 5-6 p. 442-
1 p.
artikel
46 Evaluation of clinical efficacy of Ninjin Yoh-eito extract granules with special reference to the quality of life of lung cancer patients 1994
11 5-6 p. 443-
1 p.
artikel
47 Evaluation of CYFRA 21-1 as a new marker for non-small cell lung cancer 1994
11 5-6 p. 432-
1 p.
artikel
48 Expression of CD44 in human lung tumors 1994
11 5-6 p. 431-
1 p.
artikel
49 Expression of heme oxygenase in arsenic-resistant human lung adenocarcinoma cells 1994
11 5-6 p. 429-
1 p.
artikel
50 Factors confounding evaluation of treatment effect in lung cancer 1994
11 5-6 p. 433-
1 p.
artikel
51 Frequent allelic deletion at a novel locus on chromosome 5 in human lung cancer 1994
11 5-6 p. 429-
1 p.
artikel
52 Functional status in women with lung cancer 1994
11 5-6 p. 443-
1 p.
artikel
53 Genetic instability of microsatellite sequences in many non-small cell lung carcinomas 1994
11 5-6 p. 428-
1 p.
artikel
54 George A. Higgins, Jr. M.D., F.A.C.S. March 30, 1917– September 3, 1994 Hansen, Heine H.
1994
11 5-6 p. 422-
1 p.
artikel
55 Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer 1994
11 5-6 p. 428-
1 p.
artikel
56 IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines 1994
11 5-6 p. 427-428
2 p.
artikel
57 IASLC news 1994
11 5-6 p. 413-421
9 p.
artikel
58 Imaging of bronchial carcinoid tumours with indium-111 pentetreotide 1994
11 5-6 p. 434-
1 p.
artikel
59 Immunohistochemical demonstration of glycoprotein 170 and glutathione S-transferase isoenzymes in normal and neoplastic bronchial tissue 1994
11 5-6 p. 430-
1 p.
artikel
60 Inefficacy of low-dose continuous oral etoposide in non-small cell lung cancer 1994
11 5-6 p. 440-
1 p.
artikel
61 Inhibition of protein-kinase-C-dependent cell proliferation of human lung cancer cell lines by the dihydropyridine dexniguldipine 1994
11 5-6 p. 431-
1 p.
artikel
62 Interleukin-1 production is defective in alveolar macrophages from patients with lung cancer 1994
11 5-6 p. 432-
1 p.
artikel
63 Long-term antimicrobial prophylaxis in lung cancer surgery: correlation between microbiological findings and empyema development Ratto, Giovanni B.
1994
11 5-6 p. 345-352
8 p.
artikel
64 Lung cancer among newspaper printers exposed to ink mist: A study of trade union members in Manchester, England 1994
11 5-6 p. 424-425
2 p.
artikel
65 Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure 1994
11 5-6 p. 426-
1 p.
artikel
66 Lung carcinoma in a rural population in Andalucia 1994
11 5-6 p. 427-
1 p.
artikel
67 Lung carcinoma in a rural population in Andalucia 1994
11 5-6 p. 427-
1 p.
artikel
68 Malignant transformation of human bronchial epithelial cells by radon-simulated α-particles 1994
11 5-6 p. 425-426
2 p.
artikel
69 Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization 1994
11 5-6 p. 429-
1 p.
artikel
70 Mortality from respiratory cancers (including lung cancer) among workers employed in formaldehyde industries 1994
11 5-6 p. 426-
1 p.
artikel
71 Multiple primary lung cancers 1994
11 5-6 p. 436-
1 p.
artikel
72 Natural IFN-α for non-small-cell lung cancer with pleural carcinosis 1994
11 5-6 p. 440-
1 p.
artikel
73 Neoadjuvant chemotherapy in non-small cell lung cancer 1994
11 5-6 p. 440-
1 p.
artikel
74 Oncoproteins as biomarkers of a preclinical form of cancer of the respiratory tract induced by environmental carcinogens 1994
11 5-6 p. 425-
1 p.
artikel
75 Ouabain-resistant non-small-cell lung-cancer cell line shows collateral sensitivity to cis-diamminedichloroplatinum(II) (CDDP) 1994
11 5-6 p. 439-
1 p.
artikel
76 Overview on small cell lung cancer in the world: Industrialized countries, third world, Eastern Europe 1994
11 5-6 p. 442-
1 p.
artikel
77 Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer Jaruga, P.
1994
11 5-6 p. 432-
1 p.
artikel
78 Planar cobalt-57 bleomycin scintigraphy compared with CT-scan in the diagnosis and staging of lung cancer Verhoeven, GT
1994
11 5-6 p. 434-
1 p.
artikel
79 Pleural mesothelioma and exposure to asbestos: Evaluation from work histories and analysis of asbestos bodies in bronchoalveolar lavage fluid or lung tissue in 131 patients 1994
11 5-6 p. 423-
1 p.
artikel
80 p53 Mutations in lung tumors: Relationship to putative susceptibility markers for cancer Ryberg, D
1994
11 5-6 p. 431-
1 p.
artikel
81 p53 mutations in primary human lung tumors and their metastases 1994
11 5-6 p. 432-
1 p.
artikel
82 Potentiation of long-term-cultured lymphokine-activated killer cell cytotoxicity against small-cell lung carcinoma by anti-CD3 x anti-(tumor-associated antigen) bispecific antibody 1994
11 5-6 p. 442-
1 p.
artikel
83 Preoperative histologic diagnosis of chest wall invasion by lung cancer using ultrasonically guided biopsy 1994
11 5-6 p. 435-
1 p.
artikel
84 Prolonged survival after high-dose rate endobronchial radiation for malignant airway obstruction 1994
11 5-6 p. 441-
1 p.
artikel
85 Proposal for a new section in Lung Cancer on ongoing randomized trials Pignon, Jean-Pierre
1994
11 5-6 p. 401-403
3 p.
artikel
86 Pulmonary cancer from the general practitioner's point of view: Experience from the health centre area of Kungsbacka, Sweden 1994
11 5-6 p. 443-444
2 p.
artikel
87 Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia Lee, JS
1994
11 5-6 p. 423-
1 p.
artikel
88 Recent advances in diagnosis and treatment of small cell and non-small cell lung cancer 1994
11 5-6 p. 443-
1 p.
artikel
89 Receptor subtype expression and responsiveness to bombesin in cultured human bronchial epithelial cells 1994
11 5-6 p. 430-
1 p.
artikel
90 Recurrence at the bronchial stump after resection of lung cancer 1994
11 5-6 p. 437-
1 p.
artikel
91 Reflex sympathetic dystrophy and lung carcinoma 1994
11 5-6 p. 433-
1 p.
artikel
92 Reproducibility of major diagnoses in a binational study of lung cancer in uranium miners and atomic bomb survivors 1994
11 5-6 p. 425-
1 p.
artikel
93 Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis 1994
11 5-6 p. 424-
1 p.
artikel
94 Risk factors of primary lung cancer and spirometry 1994
11 5-6 p. 424-
1 p.
artikel
95 Schedule dependency of IV-paclitaxel against SC-M 109 mouse lung cancer 1994
11 5-6 p. 437-438
2 p.
artikel
96 Second line treatment (2 LT) in small cell lung cancer (SC) 1994
11 5-6 p. 438-439
2 p.
artikel
97 Serum markers CASA, CEA, CYFRA 21-1, MSA, NSE, TPA and TPS in lung cancer 1994
11 5-6 p. 426-427
2 p.
artikel
98 Silicosis and lung cancer risk in underground uranium miners 1994
11 5-6 p. 427-
1 p.
artikel
99 Single cerebral metastases of bronchopulmonary cancers 1994
11 5-6 p. 433-
1 p.
artikel
100 Small cell lung cancer and topoisomerases 1994
11 5-6 p. 439-
1 p.
artikel
101 Small cell lung cancer: Patients surviving longer than thirty months 1994
11 5-6 p. 433-
1 p.
artikel
102 Small cell lung cancer treatment 1994
11 5-6 p. 442-443
2 p.
artikel
103 Squamous cell carcinoma antigen (SCC Ag) in the diagnosis and prognosis of lung cancer 1994
11 5-6 p. 435-436
2 p.
artikel
104 Surgical resection for small cell carcinoma of the lung: A retrospective study 1994
11 5-6 p. 436-437
2 p.
artikel
105 Surgical treatment of the non-small cell lung cancer: Stage I (T1N0-T2N0) and stage II (T1N1-T2N1). Prognostic factors, results and recurrence 1994
11 5-6 p. 437-
1 p.
artikel
106 The Alpha-Tocopherol, Beta-Carotene lung cancer prevention study: Design, methods, participant characteristics, and compliance 1994
11 5-6 p. 424-
1 p.
artikel
107 The β-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: Smokers and asbestos-exposed workers 1994
11 5-6 p. 423-
1 p.
artikel
108 The effect of suramin on human lung cancer cell line in vitro 1994
11 5-6 p. 427-
1 p.
artikel
109 The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study Kiriakogiani-Psaropoulou, Panagiota
1994
11 5-6 p. 353-364
12 p.
artikel
110 Three-step tumor pre-targeting in lung cancer immunoscintigraphy 1994
11 5-6 p. 434-
1 p.
artikel
111 Tobacco policy recommendations of the International Association for the Study of Lung Cancer (IASLC): a ten point program 1994
11 5-6 p. 405-407
3 p.
artikel
112 Treatment evaluation of combined modality therapy: ‘What can we obtain today from Phase II trials?’ 1994
11 5-6 p. 438-
1 p.
artikel
113 Treatment of small cell lung cancer. Recent experience of the EORTC lung cancer cooperative group 1994
11 5-6 p. 442-
1 p.
artikel
114 Treatment of small cell lung cancer: The Copenhagen experience 1994
11 5-6 p. 441-
1 p.
artikel
115 Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852 1994
11 5-6 p. 430-431
2 p.
artikel
116 Two cases of primary lung cancer presenting as nephrotic syndrome and a review of the literature in the past 15 years 1994
11 5-6 p. 433-
1 p.
artikel
117 Video assisted thoracoscopic surgery 1994
11 5-6 p. 437-
1 p.
artikel
118 Weekly carboplatin and VM-26 for elderly patients with small-cell lung cancer 1994
11 5-6 p. 438-
1 p.
artikel
                             118 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland